IP Verse

Beta-2 Microglobulin-Deficient Cells - EP2699593

EP2699593

UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION
Application Number
EP12720040A
Filing Date
Apr 18, 2012
Status
Patent Maintained As Amended
Oct 2, 2020
Grant Date
Nov 4, 2020
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2838548B1
EP2828218B9

Bibliography

The patent EP2699593B2 was granted to University OF Washington Through ITS Center FOR Commercialization on Nov 4, 2020 following the initial filing on Apr 18, 2012 under the application number EP12720040A . The current legal status of the patent is Patent Maintained As Amended.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

JAMES POOLEMay 30, 2018 -

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents